Benzodiazepine receptor quantification in Huntington's disease with [(123)I]iomazenil and SPECT

OBJECTIVES—Increasing evidence suggests that metabolic changes predate neuronal death in Huntington's disease and emission tomography methods (PET and SPECT) have shown changes in glucose consumption and receptor function in early and possibly even presymptomatic disease. Because the GABA(A)-be...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Pinborg, L, Videbak, C, Hasselbalch, S, Sorensen, S, Wagner, A, Paulson, O, Knudsen, G
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Group 2001
Materias:
Papers
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC1737353/
https://ncbi.nlm.nih.gov/pubmed/11309461
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/jnnp.70.5.657
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares